Provided By GlobeNewswire
Last update: May 1, 2025
- Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials
- Pliant will reduce its current workforce by approximately 45%
PLIANT THERAPEUTICS INC
NASDAQ:PLRX (5/2/2025, 8:17:34 PM)
1.69
+0.07 (+4.32%)
Find more stocks in the Stock Screener